4119 ACCORD Trial participants randomised to target HbA1c < 6.0 % ( 42 mmol/mol ) for 4.0 1.2 years were systematically transitioned to target HbA1c 7.0-7 .9 % ( 53-63 mmol/mol ) and followed for an additional 1.1 0.2 years .